|
|
13M A Kamm
![]() Summary for 2004 [at-glance overview of M A Kamm work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author M A Kamm. According to available data, in 2004 M A Kamm published at least 13 articles. This work was completed in collaboration with several authors including Hart, A L and Nicholls, R J. Many other authors have collaborated with M A Kamm as well. There is at least one grant awarded to support this work. All time total of the grant awards on file exceeds $1.
M A Kamm is a key opinion leader in the specific area of Azathioprine. This author's rank is 3 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that M A Kamm professional interests are focused around "chronic intestinal pseudo-obstruction", "beta7 memory cells" and "mucosal blood flow". These might also be referred to as "memory cells", "faecal incontinence" or "ulcerative colitis". Statistical analysis shows that M A Kamm's writing is likely to contains terms "patients", "cells", "disease", "remission", "treatment" and "probiotic".
The affiliation of M A Kamm is uncertain, but might be related to St Mark's Hospital, London, UK. Luckily, several email addresses are on file. Images [images we found on the Internet for M A Kamm]loading...
Do you know M A Kamm who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to M A Kamm]Year 2004 Charts [M A Kamm frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of M A Kamm publication and funding history for the range of years]Emails (5) [email addresses extracted from M A Kamm affiliations]hidden to prevent spam, click here to reveal M A Kamm Coauthors (38) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (9) [condensed summary of the M A Kamm affiliations, the leading number and the color conveys importance]- 3St Mark's Hospital, London, UK.
2Physiology Unit, St Mark's Hospital, Harrow, UK. 2Department of Physiology, Gastroenterology, St Mark's Hospital, Watford Road, Harrow HA1 3UJ, UK. 1University Hospital of North Tees, Stockton-on-Tees, Teesside TS19 8PE, UK. 1Antigen Presentation Research Group, Faculty of Medicine Imperial College London, Northwick Park Campus, Watford Road, Harrow, Middlesex HA1 3UJ, UK. 1Evangelisches Krankenhaus Kalk, University of Cologne, Germany. 1St Mark's Hospital, Harrow, United Kingdom. 1St Mark's Hospital, Watford Road, Harrow, UK. 1Departments of Medicine, Surgery, and Pathology, St Mark's Hospital, London, UK.
Key Opinion Leader In [M A Kamm is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 3Azathioprine | 8Colitis, Ulcerative | 14Probiotics | 59Intestinal Mucosa | 65Crohn Disease | 127Chronic Disease | 129Recurrence | 182Quality of Life | 970Prospective Studies
Keywords (32) [keywords assigned to M A Kamm articles by PubMed, the leading number and the color conveys importance]- 13Humans | 9Middle Aged | 9Adult | 9Female | 9Male | 5Aged | 5Colitis, Ulcerative | 4Treatment Outcome | 3Crohn Disease | 3Probiotics | 3Azathioprine | 3Intestinal Mucosa | 3Chronic Disease | 3Recurrence | 3Prospective Studies | 3Quality of Life | 2Immunosuppressive Agents | 2Th1 Cells | 2Lumbosacral Plexus | 2Anti-Inflammatory Agents, Non-Steroidal | 2Interleukin-10 | 2Mesalamine | 2Fecal Incontinence | 2Electric Stimulation Therapy | 26-Mercaptopurine | 2Remission Induction | 1Cytokines | 1Colon | 1Constipation | 1Adolescent | 1Patient Satisfaction | 1Receptors, Lymphocyte Homing
M A Kamm Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; M A Kamm might be a good expert witness on these terms]- 36patients | 24cells | 21disease | 20remission | 18treatment | 16probiotic | 14beta7 | 13risk | 13memory | 13incontinence | 13faecal | 12maintaining | 12colitis | 12ulcerative | 11dendritic | 11crohn | 10production | 9cell | 9dose | 9blood | 9may | 9cancer | 8increased | 8effective | 8vsl | 8study | 8bacteria | 8therapy | 7population | 7normal | 7mesalazine | 7effects
- 12memory cells | 12faecal incontinence | 12ulcerative colitis | 11crohn disease | 10maintaining remission | 6beta7 memory | 6dendritic cells | 6probiotic bacteria | 6intestinal pseudo-obstruction | 6chronic intestinal | 5coli nissle | 5mg kg | 5normal looking | 5mucosal blood | 5sacral nerve | 5blood flow | 5nerve stimulation | 5dendritic cell | 4stimulation faecal | 4looking colonoscopy | 4inflammatory bowel | 4kg day | 4cancer risk | 4crossover study | 4incontinence constipation | 4cytokine production | 4active disease | 4azathioprine dose | 3macroscopically normal | 3escherichia coli | 3post-inflammatory polyps | 3treatment chronic
- 6chronic intestinal pseudo-obstruction | 5beta7 memory cells | 5mucosal blood flow | 5sacral nerve stimulation | 4normal looking colonoscopy | 4stimulation faecal incontinence | 4nerve stimulation faecal | 4mg kg day | 4faecal incontinence constipation | 3escherichia coli nissle | 3macroscopically normal looking | 3treatment chronic intestinal | 3maintaining remission crohn | 3inflammatory bowel disease | 3erythromycin treatment chronic | 3daily dose probiotic | 3remission crohn disease | 3intestinal-homing memory cells | 3crohn disease patients | 3recurrent refractory pouchitis | 2beta7 beta7 memory | 2faecal incontinence uk | 2quantitative functional characteristics | 2prospective evaluation intestinal | 2maintaining remission recurrent | 2remission recurrent refractory | 2events among patients | 2neoplasia risk uc | 2evaluation intestinal homing | 2patients ulcerative colitis | 2homing memory cells | 2functional characteristics intestinal-homing
Reader's Comments (0) [comments posted by readers of M A Kamm profile]Funding (1) [selected NIH grants to M A Kamm and the award amounts for recent years]- DHHS VALUE-ADDED NETWORK SERVICES (DHHS VAN) (KAMM, MARILYN - 1989)
| Grant # | Award Year | Award Amount, USD | | 1N01LM093506-000 | 1999 | $1 | | Total up to 2004 | $1 |
M A Kamm Articles (13) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. (2004) >> University Hospital of North Tees, Stockton-on-Tees, Teesside TS19 8PE, UK. 2Williams, C B, 1Rumbles, S, 6Talbot, I C, 15Forbes, A, 2Wilkinson, K H, 7Saunders, B P, 2Rutter, M D, 2Price, A B, 13Kamm, M A, 2Schofield, G.Systematic review of sacral nerve stimulation for faecal incontinence and constipation. (2004) >> Physiology Unit, St Mark's Hospital, Harrow, UK. 6Fraser, C, 11Nicholls, R J, 8Grant, A M, 2Mowatt, G, 6Glazener, C M A, 3Jarrett, M E D, 13Kamm, M A.Modulation of human dendritic cell phenotype and function by probiotic bacteria. (2004) >> Antigen Presentation Research Group, Faculty of Medicine Imperial College London, Northwick Park Campus, Watford Road, Harrow, Middlesex HA1 3UJ, UK. 4Hart, A L, 1Lammers, K, 3Vitali, B, 3Brigidi, P, 3Campieri, M, 4Gionchetti, P, 13Kamm, M A, 4Stagg, A J, 5Knight, S C, 4Rizzello, F.Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. (2004) >> Evangelisches Krankenhaus Kalk, University of Cologne, Germany. 8Schulze, J, 15Stolte, M, 1Pokrotnieks, J, 2Lukas, M, 1Fixa, B, 6Beglinger, C, 13Kamm, M A, 1Weismueller, J, 1Kascak, M, 2Wolff, C, 1Fric, P, 6Kruis, W.Review article: chronic active disease and maintaining remission in Crohn's disease. (2004) >> St Mark's Hospital, London, UK. 13Kamm, M A.Prospective evaluation of intestinal homing memory T cells in ulcerative colitis. (2004) >> St Mark's Hospital, Harrow, United Kingdom. 4Hart, A L, 13Kamm, M A, 4Stagg, A J, 5Knight, S C.Azathioprine dose escalation in inflammatory bowel disease. (2004) >> St Mark's Hospital, London, UK. 4Hart, A L, 4Emmanuel, A V, 1Hayward, C M M, 13Kamm, M A, 1Rayner, C K.Sacral nerve stimulation for faecal incontinence in the UK. (2004) >> Department of Physiology, St Mark's Hospital, Watford Road, Harrow HA1 3UJ, UK. 3Duthie, G S, 11Nicholls, R J, 3Varma, J S, 3Jarrett, M E D, 13Kamm, M A.Behavioural therapy (biofeedback) for solitary rectal ulcer syndrome improves symptoms and mucosal blood flow. (2004) >> Physiology Unit, St Mark's Hospital, Harrow, UK. 1Vaizey, C J, 4Emmanuel, A V, 3Jarrett, M E D, 13Kamm, M A.Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. (2004) >> St Mark's Hospital, London, UK. 1Shand, A G, 4Emmanuel, A V, 13Kamm, M A.Antagonist: Early surgical intervention in ulcerative colitis. (2004) >> Department of Gastroenterology, St. Mark's Hospital, Watford Road, Harrow HA1 3UJ, UK. 13Kamm, M A.Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. (2004) >> St Mark's Hospital, Watford Road, Harrow, UK. 4Hart, A L, 13Kamm, M A, 4Stagg, A J, 5Knight, S C.Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. (2004) >> Departments of Medicine, Surgery, and Pathology, St Mark's Hospital, London, UK. 1Poggioli, G, 14Schreiber, S, 11Nicholls, R J, 6Talbot, I C, 6Mimura, T, 3Campieri, M, 4Gionchetti, P, 13Kamm, M A, 1Helwig, U, 4Rizzello, F.
Science Trivia (2) [Interactive math & science trivia questions]
|
|